126 related articles for article (PubMed ID: 36083516)
1. Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy.
Opsteen S; Moylan D; Taiwo BO; Robertson KR; Overton ET; Cutter GR; Sabbaj S; Heath SL; Shacka JJ
J Acquir Immune Defic Syndr; 2022 Dec; 91(5):485-489. PubMed ID: 36083516
[TBL] [Abstract][Full Text] [Related]
2. Circulating brain-derived extracellular vesicles expressing neuroinflammatory markers are associated with HIV-related neurocognitive impairment.
de Menezes EGM; Liu JS; Bowler SA; Giron LB; D'Antoni ML; Shikuma CM; Abdel-Mohsen M; Ndhlovu LC; Norris PJ
Front Immunol; 2022; 13():1033712. PubMed ID: 36601110
[TBL] [Abstract][Full Text] [Related]
3. Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.
Kalayjian RC; Robertson KR; Albert JM; Fichtenbaum CJ; Brown TT; Taiwo BO;
J Acquir Immune Defic Syndr; 2019 Jun; 81(2):e49-e54. PubMed ID: 30939531
[TBL] [Abstract][Full Text] [Related]
4. Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.
Robertson KR; Jiang H; Kumwenda J; Supparatpinyo K; Marra CM; Berzins B; Hakim J; Sacktor N; Campbell TB; Schouten J; Mollan K; Tripathy S; Kumarasamy N; La Rosa A; Santos B; Silva MT; Kanyama C; Firhnhaber C; Murphy R; Hall C; Marcus C; Naini L; Masih R; Hosseinipour MC; Mngqibisa R; Badal-Faesen S; Yosief S; Vecchio A; Nair A;
Clin Infect Dis; 2019 May; 68(10):1733-1738. PubMed ID: 30219843
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.
Cantres-Rosario Y; Plaud-Valentín M; Gerena Y; Skolasky RL; Wojna V; Meléndez LM
AIDS; 2013 Jan; 27(3):347-56. PubMed ID: 23291538
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.
Eckard AR; Rosebush JC; O'Riordan MA; Graves CC; Alexander A; Grover AK; Lee ST; Habib JG; Ruff JH; Chahroudi A; McComsey GA
Antivir Ther; 2017; 22(8):669-680. PubMed ID: 28327462
[TBL] [Abstract][Full Text] [Related]
7. Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIV.
Mastrorosa I; Pinnetti C; Brita AC; Mondi A; Lorenzini P; Del Duca G; Vergori A; Mazzotta V; Gagliardini R; Camici M; De Zottis F; Fusto M; Plazzi MM; Grilli E; Bellagamba R; Cicalini S; Antinori A
Clin Infect Dis; 2023 Feb; 76(3):e629-e637. PubMed ID: 35982541
[TBL] [Abstract][Full Text] [Related]
8. Lifetime antiretroviral exposure and neurocognitive impairment in HIV.
Amusan P; Power C; Gill MJ; Gomez D; Johnson E; Rubin LH; Fujiwara E
J Neurovirol; 2020 Oct; 26(5):743-753. PubMed ID: 32720232
[TBL] [Abstract][Full Text] [Related]
9. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
[TBL] [Abstract][Full Text] [Related]
10. Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy.
Bangirana P; Ruel TD; Boivin MJ; Pillai SK; Giron LB; Sikorskii A; Banik A; Achan J
J Int AIDS Soc; 2017 Oct; 20(2):. PubMed ID: 29052340
[TBL] [Abstract][Full Text] [Related]
11. Circulating plasma-derived extracellular vesicles expressing bone and kidney markers are associated with neurocognitive impairment in people living with HIV.
Marques de Menezes EG; Bowler SA; Shikuma CM; Ndhlovu LC; Norris PJ
Front Neurol; 2024; 15():1383227. PubMed ID: 38725641
[TBL] [Abstract][Full Text] [Related]
12. [Neurocognitive impairment and characteristics of neurocognitive performance among people with HIV on antiretroviral treatment].
Xia JJ; Wang SL; Hu YF; Shen WW; Lin HJ; Shi RZ; Ma ZH; Li ZH; Li SZ; Ding YY; Chen XX; He N
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1651-1657. PubMed ID: 36456499
[No Abstract] [Full Text] [Related]
13. Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.
Nichols SL; Bethel J; Kapogiannis BG; Li T; Woods SP; Patton ED; Ren W; Thornton SE; Major-Wilson HO; Puga AM; Sleasman JW; Rudy BJ; Wilson CM; Garvie PA;
J Neurovirol; 2016 Apr; 22(2):218-30. PubMed ID: 26463526
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda.
Rubin LH; Saylor D; Nakigozi G; Nakasujja N; Robertson K; Kisakye A; Batte J; Mayanja R; Anok A; Lofgren SM; Boulware DR; Dastgheyb R; Reynolds SJ; Quinn TC; Gray RH; Wawer MJ; Sacktor N
J Neurovirol; 2019 Dec; 25(6):800-813. PubMed ID: 31218522
[TBL] [Abstract][Full Text] [Related]
15. Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy.
Fields JA; Swinton MK; Soontornniyomkij B; Carson A; Achim CL
AIDS; 2020 Jun; 34(7):1001-1007. PubMed ID: 32073451
[TBL] [Abstract][Full Text] [Related]
16. Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial.
Decloedt EH; Lesosky M; Maartens G; Joska JA
AIDS Res Ther; 2017 Feb; 14(1):6. PubMed ID: 28160772
[TBL] [Abstract][Full Text] [Related]
17. Macrophage derived cystatin B/cathepsin B in HIV replication and neuropathogenesis.
Rivera LE; Colon K; Cantres-Rosario YM; Zenon FM; Melendez LM
Curr HIV Res; 2014; 12(2):111-20. PubMed ID: 24862331
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.
Wagner GA; Chaillon A; Liu S; Franklin DR; Caballero G; Kosakovsky Pond SL; Vaida F; Heaton RK; Letendre SL; Grant I; Richman DD; Smith DM
AIDS; 2016 Nov; 30(17):2591-2597. PubMed ID: 27536983
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of CNS Viral Seeding by HIV
Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
[TBL] [Abstract][Full Text] [Related]
20. Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment.
Robertson K; Landay A; Miyahara S; Vecchio A; Masters MC; Brown TT; Taiwo BO
J Neurovirol; 2020 Feb; 26(1):107-113. PubMed ID: 31468473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
